FDA issues warning letters to distributors of food, dietary supplements and unapproved drugs that contain ...

Abstract Number: 1833 Summary: A novel human IL-12 partial agonist (STK-026) has been designed to more selectively engage antigen activated T-cells and to reduce stimulation of NK cells.

A synthetic tryptamine, this serotonergic hallucinogen acts as a partial agonist at serotonin (5-hydroxytryptamine [5-HT]) 5-HT2A receptors.

The study’s estimated primary completion date is June 2024. A second Synthekine cancer candidate, STK-012, is an IL-2 partial agonist using the engineered cytokine partial agonist platform.

SAN DIEGO — Tavapadon, a novel and highly selective partial agonist of dopamine D1 and D5 receptors, significantly improved motor function without increasing impulse control disorders in ...

DelveInsight's Parkinson's Disease Pipeline report depicts a robust space with 130+ active players working to develop 150+ ...

Codeine sulfate 15mg, 30mg, 60mg; tabs. Codeine sulfate is an opioid agonist relatively selective for the mu-opioid receptor, but with a much weaker affinity than morphine. The analgesic ...

Buprenorphine is a partial agonist, meaning it has those effects at some doses but also has a “ceiling effect”—higher doses don’t produce more euphoria and are less likely to cause ...